ASPAR PHARMACEUTICALS LIMITED – MIA 8977
| Authorisation Number | UK MIA 8977 |
| Category | MIA |
| Holder | ASPAR PHARMACEUTICALS LIMITED |
| Registered Address | ASPAR PHARMACEUTICALS LIMITED, ALBANY HOUSE, ACREWOOD WAY, ST. ALBANS, AL4 0JY, UNITED KINGDOM |
| Authorisation Date | Jun 26, 2026 |
| Legal Basis | HumanRegulation 17 of The Human Medicines Regulations 2012 (SI 2012/1916) |
| Sites | 1 |
| Manufacturing Operations | 1.2 1.2.1 1.2.1.1 1.2.1.13 1.2.1.8 1.2.2 1.4 1.4.1 1.4.1.1 1.5 1.5.1 1.5.1.1 1.5.1.13 1.5.1.8 1.5.2 1.6 1.6.3 |
| Importation Operations | 2.1 2.1.3 2.2 2.2.2 2.3 2.3.2 2.3.4 |
| MHRA Link | View on MHRA Website |
Sites (1)
ASPAR PHARMACEUTICALS LIMITED
BOTH
Country: UNITED KINGDOMProduct Class: Human Medicinal Products
Manufacturing
1.2 — Non-sterile products
1.2.1 — Non-Sterile Products (processing operations for the following dosage forms)
1.2.1.1 — Capsules, hard shell
1.2.1.8 — Other solid dosage forms
1.2.1.13 — Tablets
1.2.2 — Batch certification
1.4 — Other products or manufacturing activity
1.4.1 — Manufacture of:
1.4.1.1 — Herbal products
1.5 — Packaging
1.5.1 — Primary packaging
1.5.1.1 — Capsules, hard shell
1.5.1.8 — Other solid dosage forms
1.5.1.13 — Tablets
1.5.2 — Secondary packaging
1.6 — Quality control testing
1.6.3 — Chemical/Physical
Importation
2.1 — Quality control testing of imported medicinal products
2.1.3 — Chemical/Physical
2.2 — Batch certification of imported medicinal products
2.2.2 — Non-sterile products
2.3 — Other Importation Activities
2.3.2 — Importation of Intermediate which undergoes further processing
2.3.4 — Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc)
Content Preview
The source document is available on KeyPedia. Sign in to view.